Seven Eight Capital’s Genomic Health, Inc. GHDX Stock Holding History

Seven Eight Capital’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,298	Closed	-$1.92M	–	817
2019 Q3	$1.92M	Buy	28,298 +1,398	+5%	+$96K	0.1%	296
2019 Q2	$1.56M	Buy	26,900 +14,600	+119%	+$865K	0.08%	311
2019 Q1	$862K	Sell	12,300 -20,800	-63%	-$1.54M	0.05%	375
2018 Q4	$2.13M	Buy	+33,100	New	+$2.32M	0.12%	223

Seven Eight Capital's GHDX Position: Q4 2019 in Review

Seven Eight Capital sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 28,298 shares — an estimated $1.92M sold.

Seven Eight Capital first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $2.13M in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Seven Eight Capital reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Seven Eight Capital sold 28,298 Genomic Health, Inc. shares in Q4 2019, an estimated $1.92M.
Seven Eight Capital first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
Seven Eight Capital's Genomic Health, Inc. position peaked at $2.13M in Q4 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Seven Eight Capital's 13F filing for Q4 2019, filed 13 Feb 2020.